The PI3K/PTEN/Akt/mTOR signaling regulated CSC activity in gefitinib-resistant A549 cells, which contained a high proportion of CXCR4+ cells endowed with an enhanced potential of self-renewal activity in vitro and tumor growth in vivo (Jung et al., 2013). This evidence concerns the gene AKT1 and neoplasm.